BioSpace News Archive

Repligen Corporation today announced the digital publication of its 2022 Sustainability Report and related reporting index disclosures.

PDS Biotechnology Corporation today announced its financial results for the quarter ended September 30, 2023.

SAB Biotherapeutics, Inc. today announced the funding of the second tranche of a previously-announced financing, raising total aggregate proceeds to date of $67.1 million.

QSAM Biosciences Inc. has signed a non-binding term sheet with Telix Pharmaceuticals Inc., a subsidiary of Telix Pharmaceuticals Limited providing material terms for the acquisition of the Company by Telix by means of a merger.

DMK Pharmaceuticals Corporation today announced financial results for the third quarter ended September 30, 2023, and provided an update on recent corporate developments.

Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), today announced financial results for the third quarter ended September 30, 2023.

Entera Bio Ltd. today reported corporate updates and financial results for the third quarter ended September 30th, 2023.

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced financial results for its fiscal first quarter ended September 30, 2023, and provided a corporate update.

Syros Pharmaceuticals today reported financial results for the quarter ended September 30, 2023 and provided a corporate update.

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2023 and Provides Business Update.